Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease
- Kevin McKernan
- Anthony M. Kyriakopoulos
- Peter A. McCullough
Quotes from paper:
“Jiang et al. note that the spike protein localizes to the nucleus and significantly alters DNA damage and repair pathways via modified VDJ recombination required for adaptive immunity 29. Many of these vaccine trials demonstrated lymophocytopenia and neutropenia 2 weeks after injection 30 31. Down regulation of the innate immune system concurrent with reduced DNA repair may lead to carcinogenesis32.”
“More than 20 months into this pandemic and we have millions of SARs-CoV-2 genomes sequenced. Lot to lot sequencing of the vaccines is non-existent. To this date, no raw reads for these vaccines exist in NCBI despite over a billion liability-free vaccinations. To fully understand RNA synthesis substitution errors, fragmentation errors or strandedness errors in the mRNA synthesis process, robust lot to lot sequencing should be performed and published. Given these mRNAs are prodrugs which code for a desired protein, where is the evidence that the conversion of this prodrug into a drug is of high fidelity? This seems to have been assumed as opposed to documented. This work suggests this assumption should be questioned. Public and transparent quality control of these often-mandated injections are required. This should include sequence verification and quality control of the various lots and evidence of the proteins these mRNA express in patients.”
Full Length Version: https://osf.io/bcsa6/
and Nepetalactone Newsletter on Substack…
https://anandamide.substack.com/p/differences-in-vaccine-and-sars-cov?r=tmpdw&utm_campaign=post&utm_medium=web&utm_source=copy